Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Met signaling in cardiomyocytes is required for normal cardiac function in adult mice.

Arechederra M, Carmona R, González-Nuñez M, Gutiérrez-Uzquiza A, Bragado P, Cruz-González I, Cano E, Guerrero C, Sánchez A, López-Novoa JM, Schneider MD, Maina F, Muñoz-Chápuli R, Porras A.

Biochim Biophys Acta. 2013 Dec;1832(12):2204-15. doi: 10.1016/j.bbadis.2013.08.008. Epub 2013 Aug 28.

2.

A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats.

Ueda H, Nakamura T, Matsumoto K, Sawa Y, Matsuda H, Nakamura T.

Cardiovasc Res. 2001 Jul;51(1):41-50.

3.

Activated Met signalling in the developing mouse heart leads to cardiac disease.

Leo C, Sala V, Morello M, Chiribiri A, Riess I, Mancardi D, Schiaffino S, Ponzetto C, Crepaldi T.

PLoS One. 2011 Feb 9;6(2):e14675. doi: 10.1371/journal.pone.0014675.

4.

Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10.

Schelter F, Grandl M, Seubert B, Schaten S, Hauser S, Gerg M, Boccaccio C, Comoglio P, Krüger A.

Clin Exp Metastasis. 2011 Dec;28(8):793-802. doi: 10.1007/s10585-011-9410-z. Epub 2011 Jul 26.

PMID:
21789719
5.

Loss of HGF/c-Met signaling in pancreatic β-cells leads to incomplete maternal β-cell adaptation and gestational diabetes mellitus.

Demirci C, Ernst S, Alvarez-Perez JC, Rosa T, Valle S, Shridhar V, Casinelli GP, Alonso LC, Vasavada RC, García-Ocana A.

Diabetes. 2012 May;61(5):1143-52. doi: 10.2337/db11-1154. Epub 2012 Mar 16.

6.

Enhanced cardiomyocyte Ca(2+) cycling precedes terminal AV-block in mitochondrial cardiomyopathy Mterf3 KO mice.

Andersson DC, Fauconnier J, Park CB, Zhang SJ, Thireau J, Ivarsson N, Larsson NG, Westerblad H.

Antioxid Redox Signal. 2011 Nov 1;15(9):2455-64. doi: 10.1089/ars.2011.3915. Epub 2011 May 25.

PMID:
21381862
7.

Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development.

Ieraci A, Forni PE, Ponzetto C.

Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15200-5. Epub 2002 Oct 23.

8.

Mouse hepatic oval cells require Met-dependent PI3K to impair TGF-β-induced oxidative stress and apoptosis.

Martínez-Palacián A, del Castillo G, Suárez-Causado A, García-Álvaro M, de Morena-Frutos D, Fernández M, Roncero C, Fabregat I, Herrera B, Sánchez A.

PLoS One. 2013;8(1):e53108. doi: 10.1371/journal.pone.0053108. Epub 2013 Jan 2.

9.

Zinc supplementation prevents cardiomyocyte apoptosis and congenital heart defects in embryos of diabetic mice.

Kumar SD, Vijaya M, Samy RP, Dheen ST, Ren M, Watt F, Kang YJ, Bay BH, Tay SS.

Free Radic Biol Med. 2012 Oct 15;53(8):1595-606. doi: 10.1016/j.freeradbiomed.2012.07.008. Epub 2012 Jul 20.

PMID:
22819979
10.

Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy.

Esaki M, Takemura G, Kosai K, Takahashi T, Miyata S, Li L, Goto K, Maruyama R, Okada H, Kanamori H, Ogino A, Ushikoshi H, Minatoguchi S, Fujiwara T, Fujiwara H.

Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H1048-57. Epub 2007 Dec 14.

12.

Inhibitory effect of hepatocyte growth factor on cardiomyocytes apoptosis is partly related to reduced calcium sensing receptor expression during a model of simulated ischemia/reperfusion.

Yan L, Zhu TB, Wang LS, Pan SY, Tao ZX, Yang Z, Cao K, Huang J.

Mol Biol Rep. 2011 Apr;38(4):2695-701. doi: 10.1007/s11033-010-0412-8. Epub 2010 Nov 19.

PMID:
21088907
13.

Expression of Foxm1 transcription factor in cardiomyocytes is required for myocardial development.

Bolte C, Zhang Y, Wang IC, Kalin TV, Molkentin JD, Kalinichenko VV.

PLoS One. 2011;6(7):e22217. doi: 10.1371/journal.pone.0022217. Epub 2011 Jul 14.

14.

C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization.

Wu YM, Liu CH, Huang MJ, Lai HS, Lee PH, Hu RH, Huang MC.

Cancer Res. 2013 Sep 1;73(17):5580-90. doi: 10.1158/0008-5472.CAN-13-0869. Epub 2013 Jul 5.

15.

Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling.

Lindner G, Menrad A, Gherardi E, Merlino G, Welker P, Handjiski B, Roloff B, Paus R.

FASEB J. 2000 Feb;14(2):319-32.

16.

Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart.

Wang P, Liu J, Li Y, Wu S, Luo J, Yang H, Subbiah R, Chatham J, Zhelyabovska O, Yang Q.

Circ Res. 2010 Mar 19;106(5):911-9. doi: 10.1161/CIRCRESAHA.109.206185. Epub 2010 Jan 14.

17.

Peroxisome proliferator-activated receptor β/δ activation in adult hearts facilitates mitochondrial function and cardiac performance under pressure-overload condition.

Liu J, Wang P, Luo J, Huang Y, He L, Yang H, Li Q, Wu S, Zhelyabovska O, Yang Q.

Hypertension. 2011 Feb;57(2):223-30. doi: 10.1161/HYPERTENSIONAHA.110.164590. Epub 2011 Jan 10.

18.

Lack of endothelial nitric oxide synthase-derived nitric oxide formation favors hypertrophy in adult ventricular cardiomyocytes.

Wenzel S, Rohde C, Wingerning S, Roth J, Kojda G, Schlüter KD.

Hypertension. 2007 Jan;49(1):193-200. Epub 2006 Oct 30.

19.

Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.

Li HL, Wang AB, Huang Y, Liu DP, Wei C, Williams GM, Zhang CN, Liu G, Liu YQ, Hao DL, Hui RT, Lin M, Liang CC.

Free Radic Biol Med. 2005 Jan 15;38(2):243-57.

PMID:
15607907
20.

Mechanical stretch induces hypertrophic responses in cardiac myocytes of angiotensin II type 1a receptor knockout mice.

Kudoh S, Komuro I, Hiroi Y, Zou Y, Harada K, Sugaya T, Takekoshi N, Murakami K, Kadowaki T, Yazaki Y.

J Biol Chem. 1998 Sep 11;273(37):24037-43.

Items per page

Supplemental Content

Write to the Help Desk